InvestorsHub Logo
icon url

justdafactss

03/05/24 10:06 PM

#230627 RE: Monroe1 #230616

It used to be bankruptcy--- Since our inception, we have been insolvent and have required debt and equity financing to maintain operations.
https://www.sec.gov/Archives/edgar/data/1175680/000155837023015718/cydy-20230531x10k.htm

there won't be a new CEO--- A guy whos been affiliated with the co since at least 2006 and the co owes $400K to.
https://www.biospace.com/article/releases/cytodyn-selects-b-quest-clinical-research-b-for-next-trial-of-hiv-aids-immune-therapy-/

Since June 1, 2021, the Company has paid Quest approximately $1.5 million for its services in conducting clinical trials of leronlimab. As of November 17, 2023, the outstanding balance owed by the Company to Quest was approximately $0.4 million.
https://www.sec.gov/Archives/edgar/data/1175680/000155837023019285/cydy-20231117x8k.htm

then they said no holds will be lifted--- Wheres that detailed 8K filing?